Basilea Pharmaceutica AG Tangible Net Worth Ratio
Basilea Pharmaceutica AG tangible net worth ratio. Basilea Pharmaceutica AG (BSLN) has a Tangible Net Worth Ratio of 99.7% as of December 2025. This metric is calculated by deducting intangible assets (CHF371.00K) from net assets (CHF127.94 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check asset allocation strategy of Basilea Pharmaceutica AG to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Basilea Pharmaceutica AG (2002–2025)
Tangible net worth ratio of Basilea Pharmaceutica AG from 2002 to 2025. This chart shows how Basilea Pharmaceutica AG's Tangible Net Worth Ratio has changed across 16 annual periods from 2002 to 2025. As of December 2025, the ratio stands at 99.7%, reflecting net assets of CHF127.94 Million with intangible assets of CHF371.00K CHF. See working capital to net assets of Basilea Pharmaceutica AG to evaluate short-term liquidity relative to the company's equity base.
Basilea Pharmaceutica AG Tangible Net Worth Ratio by Year (2002–2025)
Basilea Pharmaceutica AG tangible net worth ratio by year from 2002 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Basilea Pharmaceutica AG from 2002 to 2025, covering 16 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Basilea Pharmaceutica AG market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CHF) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.7% | CHF127.94 Million | CHF371.00K | CHF282.00 Million | ▲ +0.2 pp |
| 2024 | 99.5% | CHF81.00 Million | CHF374.00K | CHF257.76 Million | ▲ +1.9 pp |
| 2015 | 97.7% | CHF14.86 Million | CHF346.00K | CHF398.74 Million | ▼ -1.9 pp |
| 2014 | 99.6% | CHF57.93 Million | CHF224.00K | CHF257.38 Million | ▲ +0.2 pp |
| 2013 | 99.4% | CHF70.87 Million | CHF432.15K | CHF299.76 Million | ▼ 0.0 pp |
| 2012 | 99.4% | CHF105.50 Million | CHF600.03K | CHF375.34 Million | ▲ +0.2 pp |
| 2011 | 99.2% | CHF153.27 Million | CHF1.16 Million | CHF237.09 Million | ▼ -0.3 pp |
| 2010 | 99.5% | CHF210.24 Million | CHF997.43K | CHF316.54 Million | ▲ +1.6 pp |
| 2009 | 97.9% | CHF97.73 Million | CHF2.05 Million | CHF206.61 Million | ▼ -0.7 pp |
| 2008 | 98.6% | CHF199.74 Million | CHF2.77 Million | CHF328.13 Million | ▼ -0.6 pp |
| 2007 | 99.2% | CHF335.10 Million | CHF2.56 Million | CHF461.45 Million | ▼ -0.6 pp |
| 2006 | 99.8% | CHF112.31 Million | CHF172.42K | CHF203.09 Million | ▼ -0.2 pp |
| 2005 | 100.0% | CHF167.87 Million | CHF0.00 | CHF255.56 Million | ▲ +0.0 pp |
| 2004 | 100.0% | CHF209.60 Million | CHF0.00 | CHF230.78 Million | ▲ +0.0 pp |
| 2003 | 100.0% | CHF90.29 Million | CHF0.00 | CHF107.02 Million | ▲ +0.0 pp |
| 2002 | 100.0% | CHF125.38 Million | CHF0.00 | CHF150.51 Million | — |